Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 601-612 of 5,650
Drug study icon
RecruitingNCT06759558

Allopregnanolone (Zuranolone) in Post-stroke Depression

This observational study is following people with Post Stroke Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Durham
DepressionDrugA study involving a medication or substance.From 21 Years to 65 Years
Countries
United States
Sponsor
Duke University
Condition
Depression
Drug study icon
RecruitingNCT04135846

Alpha-1 Blockade for Addiction (AUD)

This summary needs review. Please check the official study record and contact the research team for details.

In Providence
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Brown University
Condition
Addiction
Biological study icon
RecruitingNCT05632497

Alteration of Symbiosis Intestinal Microbiota on people with Eating disorders

This observational study is following people with Eating disorders, Dysbiosis, or Anxious Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Villejuif
Eating disorders, DepressionBiologicalOver 18 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Eating disorders, Depression
Other study type icon
RecruitingNCT05968313

Altered Neural Pain Empathic Reactivity in NSSI Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In Chengdu
SuicidalityOtherFrom 15 Years to 18 Years
Countries
China
Sponsor
University of Electronic Science and Technology of China
Condition
Suicidality
Device study icon
RecruitingNCT02916810

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

This study is looking at care and outcomes for people with Schizophrenia and Related Disorders. Some participants may receive Sham rTMS stimulation instead of the study treatment, and direct benefit is not guaranteed.

In Houston
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia
Drug study icon
RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Chandler
Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Birmingham
DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom
Sponsor
Alto Neuroscience
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.